Evidence map›Paper›PMID 31058877›Full record

ArticleJournal of clinical medicine2019

CA125 as a Marker of Heart Failure in the Older Women: Population-Based Analysis.

Weronika Bulska-Będkowska, Elżbieta Chełmecka, Aleksander J Owczarek, Katarzyna Mizia-Stec, Andrzej Witek, Aleksandra Szybalska, Tomasz Grodzicki, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Weronika Bulska-BędkowskaDepartment of Internal Diseases and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia, 40-027 Katowice, Poland. lek.weronikabulska@gmail.com.
Elżbieta ChełmeckaDepartment of Statistics, Department of Instrumental Analysis, School of Pharmacy and Laboratory Medicine in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland. echelmecka@sum.edu.pl.ORCID 0000-0002-0111-438X
Aleksander J OwczarekDepartment of Statistics, Department of Instrumental Analysis, School of Pharmacy and Laboratory Medicine in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland. aowczarek@paintbox.com.pl.ORCID 0000-0003-1179-6932
Katarzyna Mizia-StecFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 40-635 Katowice, Poland. kmizia@op.pl.
Andrzej WitekDepartment of Gynecology and Obstetrics, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland. awitek@sum.edu.pl.
Aleksandra SzybalskaInternational Institute of Molecular and Cell Biology, Warsaw 02-109, Poland. a.szybalska@iimcb.gov.pl.
Tomasz GrodzickiDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, 31-531 Cracow, Poland. tomekg@su.krakow.pl.
Magdalena Olszanecka-GlinianowiczHealth Promotion and Obesity Management Unit, Department of Pathophysiology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland. magols@esculap.pl.
Jerzy ChudekDepartment of Internal Diseases and Oncological Chemotherapy, School of Medicine in Katowice, Medical University of Silesia, 40-027 Katowice, Poland. chj@poczta.fm.ORCID 0000-0002-6367-7794
Medical University of Silesia · PLInternational Institute of Molecular and Cell Biology · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Cancer antigen 125 (CA125) is a glycoprotein that is expressed by tissue derived from coelomic epithelium in the pleura, peritoneum, pericardium. It has been shown that CA125 concentrations are correlated with NT-proBNP in older with congestive heart failure (HF). We conducted a study on the association between concentrations of CA125 and NT-proBNP in a population-based cohort of older Polish women. (2) Methods: The current research is sub-study of a large, cross-sectional research project (PolSenior). The study group consisted of 1565 Caucasian women aged 65-102 years. To assess the relationship between CA125 and other variables a stepwise backward multivariate normal and skew-t regression analyses were performed. (3) Results: The median of CA125 concentration was 13.0 U/mL and values over the upper normal range limit (35 U/mL) were observed in 5.1% (

Indexed as

carbohydrate antigen-125heart failureinflammatory markerolder women

Identifiers

PMID31058877
PMCPMC6572540
OpenAlexW2943195199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.